|Home | About | Journals | Submit | Contact Us | Français|
A Major Transition in Neuro-Oncology
After a distinguished tenure as chairperson of the Communications Committee for 11 years, Oliver Bögler, PhD, of The University of Texas M. D. Anderson Cancer Center, is stepping down from his position. Assuming the duties will be Christopher E. Pelloski, MD, and Erik P. Sulman, MD, PhD, both from the Department of Radiation Oncology, also at M. D. Anderson. Dr. Pelloski will coordinate the News section, which appears in every issue of Neuro-Oncology, while Dr. Sulman will coordinate the journal’s Web site. Please send all correspondence to the appropriate individual (see details below).
The journal editors and staff and the Society for Neuro-Oncology thank Dr. Bögler for his years of service and look forward to working with Drs. Pelloski and Sulman going forward.
The Ben and Catherine Ivy Foundation Announces 2008 Awards
On January 15, 2009, the Ben and Catherine Ivy Foundation announced awards totaling more than $7 million for five new patient-focused research projects. These projects focus on the improvement of the survival and quality of life for all people with brain tumors. The 2008 funds follow the $3.4 million awarded by the Ivy Foundation to brain tumor research projects earlier in 2008, its initial year of operation.
2008 Ivy Foundation Award Recipients
Allen Institute for Brain Science and the Swedish Neuro-science Institute
Ralph Puchalski, PhD, and Greg Foltz, MD, “The Ivy GBM Atlas Project: Anatomic gene expression atlas of human glioblastoma”
M. D. Anderson Cancer Center
Ken Aldape, MD, and Fred Lang, MD, “Glioma cancer stem cells and tumor-derived mesenchymal stem cells: Role and crosstalk in human gliomas”
University of Calgary
Peter A. Forsyth, MD, FRCPC, “p75ntr is a rational drug target for malignant glioma”
University of California, Los Angeles
Paul Mischel, MD, and Tim Cloughesy, MD, “Development and implementation of novel molecular diagnostic tools to guide combination therapy for malignant glioma patients”
University of Pennsylvania
George Coukos, MD, PhD, “Targeting glioblastoma through tumor endothelial marker-1 (TEM-1)”
World Federation of Neuro-Oncology 2009 jointly with the Sixth Meeting of the Asian Society for Neuro-Oncology
May 11–14, 2009
Pacifico Yokohama, Japan
On behalf of Prof. Masao Matsutani and the organizers of the Asian Society for Neuro-Oncology, we are pleased to announce plans for the 3rd Quadrennial Meeting of the World Federation of Neuro-Oncology, in conjunction with the 6th Meeting of the Asian Society for Neuro-Oncology.
For more information on the meeting and the submission of abstracts, visit the Web site at http://wfno2009.umin.ne.jp/.
Additional information may be obtained from the meeting secretariat:
Yoko Nishikawa Nobuko, Baba Secretariat
The 3rd Quadrennial Meeting of the World
Federation of Neuro-Oncology jointly with the 6th
Meeting of the Asian Society for Neuro-Oncology
c/o Convex Inc., Ichijoji Bldg.
2–3–22 Azabudai, Minato-ku
Tokyo 106–0041, Japan
Please send all items you would like to have included in future issues of Neuro-Oncology to Christopher E. Pelloski, MD, Brain Tumor Center and Div. of Radiation Oncology, Unit 97, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030; phone: 713-563–2415; fax: 713-563–2331; e-mail: gro.cno-oruen-cos@swenyteicos.
To submit a posting for the SNO Web site, please contact Erik P. Sulman, MD, PhD, Div. of Radiation Oncology, Unit 97, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030; phone: 713-563–2338; fax: 713-563–2331; e-mail: gro.nosrednadm@namluspe.